NERVGEN PHARMA CORP. Tax Effect From Change In Tax Rate
NERVGEN PHARMA CORP. (NGEN) reported Tax Effect From Change In Tax Rate of -CAD 294.00 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:TaxEffectFromChangeInTaxRate · last filed 2026-03-31
| Period end | Tax Effect From Change In Tax Rate 12 month |
|---|---|
| 2025-12-31 | -294.00K CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 25.00K CAD 40-F · filed 2026-03-31 |